Outlook Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Outlook Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.83 | $-1.01 | 17.8 % |
Mar 2024 | 2024-05-15 | $-1.55 | $-0.85 | -82.3 % |
Jun 2023 | 2023-08-14 | $-1.60 | $-1.00 | -60.0 % |
Mar 2023 | 2023-05-15 | $-0.60 | $-1.20 | 50.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2021 | 2021-12-22 | $0 | $300.00K | -100.0 % |
Jun 2021 | 2021-08-13 | $0 | $320.00K | -100.0 % |
Mar 2021 | 2021-05-14 | $0 | $320.00K | -100.0 % |
Outlook Therapeutics (OTLK) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on August 14, 2024 for Q3.
The Actual EPS was $-0.83, which beat the estimate of $-1.01.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.